Progress in the surgical treatment of malignant liver tumors in children

Cancer Treatment Reviews

Volumn 36, Issue 4, 2010, Pages 360-371

  Otte, Jean Bernard ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Chemotherapy; Hepatoblastoma; Hepatocellular carcinoma; Liver transplantation; Malignant liver tumors; Surgical resection

Indexed keywords

ALPHA FETOPROTEIN; CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; IFOSFAMIDE; THALIDOMIDE; VINCRISTINE;

CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE FREE SURVIVAL; HEPATOBLASTOMA; HISTOPATHOLOGY; HUMAN; INCIDENCE; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER TUMOR; MORBIDITY; PORTAL VEIN THROMBOSIS; PROGNOSIS; REVIEW; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT CONTRAINDICATION;

CARCINOMA, HEPATOCELLULAR; CHILD; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM STAGING;

EID: 77953023086     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2010.02.013     Document Type: Review

References (66)

1. Darbari A., Sabin KM Shapiro C.N., Schwarz K.B. Epidemiology of primary hepatic malignancies in US children. Hepatology 2003, 38:560-566.
2. De Ugarte D.A., Atkinson J.B. Liver tumors. Pediatric surgery 2006, 502-505. Mosby-Elsevier, Philadelphia. 6th ed. J.L. Grosfeld, J.A. O'Neill, E.W. Fonkalsrud, A.G. Coran (Eds.).
3. Ding S.F., Michail N.E. Habib NA genetic changes in hepatoblastoma. J Hepatol 1994, 20:672-675.
4. Vaughan W.G., Sanders D.W., Grosfeld J.L., et al. Favorable outcome in children with Beckwith-Wiedemann syndrome and intra-abdominal malignant tumors. J Pediatr Surg 1995, 30:1042-1044.
5. Thomas D., Pritchard J., Davidson R., et al. Familial hepatoblastoma and APC gene mutations: renewed call for molecular research. Eur J Cancer 2003, 39:2200-2204.
6. Hughes L.I., Michels W. Risk of hepatoblastoma in familial adenomatous polyposis. Am J Med Genet 1992, 43:1023-1025.
7. Garber J.E., Li F.P., Kingston J.E., et al. Hepatoblastoma and familial adenomatous polyposis. J Natl Cancer Inst 1988, 80:1626-1628.
8. Ammann R.A., Plaschkes J., Leibundgut K. Congenital hepatoblastoma: a distinct entity?. Med Pediatr Oncol 1999, 32:466-468.
9. Sinta L., Freud N., Dulitzki F. Hemoperitoneum as the presenting sign of hepatoblastoma in the newborn. Pediatr Surg Int 1992, 7:131-133.
10. Brown J., Perilongo G., Shafford E., et al. Pretreatment prognostic factors for children with hepatoblastoma-results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 2000, 36:1418-1425.
11. Schnater J.M., Aronson D.C., Plaschkes J., et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 2002, 94:1111-1120.
12. Czauderna P., Otte J.B., Pritchard J., et al. Guidelines for surgical treatment of hepatoblastoma in the modern era. Recommendations from the Childhood Liver Tumor Strategy Group (SIOPEL) of the International Society of Pediatric Oncology (SIOP). Eur J Cancer 2005, 41:1031-1036.
13. Haas J.E., Muzsynski K.A., Krailo M., et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 1989, 4:1082-1095.
14. Aronson D., Schnater J.M., Staalman C., et al. The predictive value of the PRETreatment EXTent of disease (PRETEXT) system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group (SIOPEL-1). J Clin Oncol 2005, 23:1245-1252.
15. Roebuck D., Aronson A., Clapuyt P., et al. PRETEXT: a revised staging system for primary malignant liver tumors of childhood. Pediatr Radiol 2007, 37:123-132.
16. Meyers RL, Malogolowkin MH, Rowland JM, Krailo M. Predictive value of the PRETEXT staging system in children with hepatoblastoma. In: Presented at the 37th annual meeting American Pediatric Surgical Association, Hilton Head, SC, May 27; 2006.
17. Stringer M. Liver tumors. Semin Pediatr Surg 2006, 9:196-208.
18. Fuchs J., Rydzynski J., Hecker H., et al. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma-a report from the German cooperative liver tumours studies HB-89 and HB-94. Eur J Pediatr Surg 2002, 12:255-261.
19. von Schweinitz D., Faundez A., Teichmann B., et al. Hepatocyte growth-factor-scatter-factor can stimulate postoperative tumor-cell proliferation in childhood hepatoblastoma. Int J Cancer 2000, 85:151-159.
20. Finegold M. Chemotherapy for suspected hepatoblastoma without effort at surgical resection is bad practice. Med Pediatr Oncol 2002, 39:484-486.
21. Ortega J.A., Krailo M.D., Haas J.E., et al. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Children Cancer Study Group. J Clin Oncol 1991, 9:2167-2176.
22. Douglass E.C., Reynolds M., Finegold M., Cantor A.B. Glycksman A cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a pediatric oncology group study. J Clin Oncol 1993, 11:96-99.
23. Ortega J.A., Douglass E., Feusner J., et al. A randomized trial of cisplatin/vincristine/5-fluorouracil vs. CCP/doxorubicin continuous infusion for the treatment of hepatoblastoma: results from the pediatric inter-group hepatoma study (abstr). Proc Am Soc Clin Oncol (ASCO) 1994, 13:416.
24. von Schweinitz D., Hecker H., Harms D., et al. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma - a report from the German cooperative pediatric liver tumor study HB-89. J Pediatr Surg 1995, 30:845-858.
25. Pritchard J., Brown J., Shafford E., et al. Cisplatin, doxorubicin and delayed surgery for childhood hepatoblastoma: a successful approach-results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol 2000, 18:3819-3828.
26. Perilongo G., Shafford E., Maibach R., et al. Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Pediatric Oncology - SIOPEL 2. Eur J Cancer 2004, 40:411-421.
27. Dall'Igna P., Cecchetto G., Toffolutti T., et al. Multifocal hepatoblastoma is there a place for partial hepatectomy?. Med Pediatr Oncol 2003, 40:113-116.
28. Couinaud C. The anatomy of the liver. Ann Ital Chir 1992, 63:693-697.
29. Wheatley J.M., Rosenfield N.S., Berger L., LaQuaglia M.P. Liver regeneration in children after major hepatectomy for malignancy-evaluation using a computer-aided technique of volume measurement. J Surg Res 1996, 61:183-189.
30. von Schweinitz D. Management of liver tumors in childhood. Semin Pediatr Surg 2006, 15:17-24.
31. Otte J.B., Pritchard J., Aronson D.C., et al. Liver transplantation for hepatoblastoma: Results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 2004, 42:74-83.
32. Austin M.T., Leys C.M., Feurer I.D., et al. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database. J Pediatr Surg 2006, 41:182-186.
33. Hoti E. Adam R liver transplantation for primary and metastatic liver cancers. Transplant Int 2008, 21:1107-1117.
34. Pimpalwar A.P., Sharif K., Ramani P., et al. Strategy for hepatoblastoma management: transplant versus nontransplant surgery. J Pediatr Surg 2002, 37:240-245.
35. Otte J.B., De Ville de Goyet J. The contribution of transplantation to the treatment of liver tumors in children. Semin Pediatr Surg 2005, 14:233-238.
36. Tiao G.M., Bobey N., Allen S., et al. The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation. J Pediatr 2005, 146:204.
37. Molmenti E.P., Wilkinson K., Molmenti H., et al. Treatment of unresectable hepatoblastoma with liver transplantation in the pediatric population. Am J Transplant 2002, 6:535-538.
38. Faraj W., Dar F., Marangoni G., Bartlett A., et al. Liver transplantation for hepatoblastoma. Liver Transplant 2008, 14(11):1614-1619.
39. Otte J.B., Meyers R. Correspondence. J Pediatr Surg 2006, 41:607-608.
40. Chardot C., Saint-Martin C., Gilles A., et al. Living-related liver transplantation and vena cava reconstruction after total hepatectomy including the vena cava for hepatoblastoma. Transplantation 2002, 73:90-92.
41. Reyes J.D., Carr B., Dvorchik I., et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular carcinoma in childhood and adolescence. J Pediatr 2000, 136:795-804.
42. Perilongo G., Brown J., Shafford E., et al. Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Pediatric Oncology on childhood liver tumors. Cancer 2000, 89:1845-1853.
43. Otte J.B., Rosati R., Janssen M. Parental experience with life-related donor liver transplantation. Pediatr Transplant 2004, 8:317-321.
44. El-Serag H.B. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2001, 5:87-107.
45. Czauderna P., MacKinley G., Perilongo G., et al. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology Group. J Clin Oncol 2002, 20:2798-2804.
46. Van Spronson F.J., Bijleveldem M., van Maldegem B.T. Wijburg IA hepatocellular carcinoma in hereditary tyrosinemia type 1 despite 2(-2 nitro 4-3 trifluoro-methylbenzenyl)1-3 cyclohexanedione therapy. J Pediatr Gastroenterol Nutr 2005, 40:90-93.
47. Franco L.M., Krishnamurthy V., Bali D., et al. Hepatocellular carcinoma in glycogen storage disease type 1a: a case series. J Inherit Metab Dis 2005, 28:153-162.
48. Hadzic N., Quaglia A., Mieli-Vergani G. Hepatocellular carcinoma in a 12 year old child with PiZZ alpha-1-antityrpsin deficiency. Hepatology 2006, 43:194-196.
49. Halvorsen RA J., Garrity S., Kun C., et al. Coexisting hepatocellular carcinoma in a patient with arteriohepatic dysplasia. Abdom Imaging 1995, 20:191-196.
50. Brunati A., Feruzi Z., Sokal E., et al. Early occurrence of hepatocellular carcinoma in biliary atresia treated by liver transplantation. Pediatr Transplant 2007, 11:117-119.
51. Whitington P.F., Freese D.K., Alonso E.M., et al. Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994, 18:134-141.
52. Scheers I., Badry V., Stephenne X. Sokal EM risk of hepatocellular carcinoma in liver mitochondrial respiratory chain disorders. J Pediatr 2005, 141:414-417.
53. Hain S.F., Fogelman I. Recent advances in imaging hepatocellular carcinoma: diagnosis, staging and response assessment functional imaging. Cancer J 2004, 10:121-127.
54. Shoup M., Gonen M., D'Angelica M., et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 2003, 7:325-330.
55. LaBerge J.M. Liver tumors. Principles of pediatric surgery 2003, Mosby, St. Louis. 2nd ed. J.A. O'Neill, J.L. Grosfeld, E.W. Fonkalsrud (Eds.).
56. Lauwers G.Y., Terris B., Balis V.J., et al. Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol 2002, 26:25-34.
57. Katzenstein H.M., Krailo M.D., Malogolowkin M.H., et al. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study. J Clin Oncol 2002, 20(12):2789-2797.
58. von Schweinitz D. Treatment of liver tumors in children. Liver tumors: current and emerging therapies 2004, Jones and Bartlett, Boston. P.A. Clavian, Y. Fong, H. Lyerly (Eds.).
59. Czauderna P., MacKinley G., Perilongo G., et al. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology Group. J Clin Oncol 2002, 20:2798-2804.
60. Beaunoyer M., Vanatta J.M., Ogihara M., et al. Outcomes of transplantation in children with primary hepatic malignancy. Pediatr Transplant 2007, 11(6):655-660.
61. Reyes J.D., Carr B., Dvorchik I., et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr 2000, 136(6):795-804.
62. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. New Engl J Med 1996, 334:693-699.
63. Yao F.Y., Ferrell L., Bass N.M., et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001, 33:1394-1403.
64. Roayaie S., Frischer J.S., Emre S.H., et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinoma larger than 5 centimetres. Ann Surg 2002, 235:533-539.
65. Terracciano L., Tornillo L. Cytogenetic alteration in liver cell tumors as detected by comparative genomic hybridization. Pathologica 2003, 95:71-82.
66. Llovet J.M., Ricci S., Mazzaferro V., et al. Sorafenib in advanced hepatocellular carcinoma. New Engl J Med 2008, 359:420-422.